Fc glycoengineering of a PD-L1 antibody harnesses Fc? receptors for increased antitumor efficacySCIENCE IMMUNOLOGYIF16.32023-03-3122PRE
Next Generation CD40 Agonistic Antibodies for Cancer ImmunotherapyFRONTIERS IN IMMUNOLOGYIF5.92022-07-1334OAAI
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targetingNATURE CANCERIF28.52022-02-2133PRE
BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patchesNATURE IMMUNOLOGYIF27.62019-03-0444PREAI
Discovery and development of COM701, a therapeutic antibody targeting the novel immune checkpoint PVRIGCANCER RESEARCHIF16.62017-07-016PRE